Loading…

Detection of Antimicrobial Resistance and Extended-Spectrum β-Lactamase Production in Klebsiella Pneumoniae Strains from Infected Neonates

The present study was designed to determine the antimicrobial resistance and extended-spectrum β-lactamase (ESBL) activities of Klebsiella pneumoniae strains isolated from the neonatal intensive care unit of Atatürk University Hospital, Erzurum, Turkey. Antibiotic susceptibility of 40 isolates was d...

Full description

Saved in:
Bibliographic Details
Published in:Journal of international medical research 2002-07, Vol.30 (4), p.445-448
Main Authors: Aktas, E, Yigit, N, Yazgi, H, Ayyildiz, A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c383t-f686288dea269c66885e8da7627c51f93ba167a7ae494a9ce35104e74de2a8ba3
cites cdi_FETCH-LOGICAL-c383t-f686288dea269c66885e8da7627c51f93ba167a7ae494a9ce35104e74de2a8ba3
container_end_page 448
container_issue 4
container_start_page 445
container_title Journal of international medical research
container_volume 30
creator Aktas, E
Yigit, N
Yazgi, H
Ayyildiz, A
description The present study was designed to determine the antimicrobial resistance and extended-spectrum β-lactamase (ESBL) activities of Klebsiella pneumoniae strains isolated from the neonatal intensive care unit of Atatürk University Hospital, Erzurum, Turkey. Antibiotic susceptibility of 40 isolates was detected by the standard disk diffusion method according to the National Committee for Clinical Laboratory Standards Guidelines. The double-disk synergy method was used to determine ESBL activity, which is associated with resistance to β-lactam antibiotics. Twenty-four (60%) of 40 K. pneumoniae strains were found to produce ESBL. Of the antibiotics tested, meropenem was found to be the most effective (100%), and ampicillin the least effective (0%). With the increasing incidence of antimicrobial resistance, which poses a clinically significant risk to vulnerable patients, it is important that clinical microbiology laboratories have accurate and timely information concerning the strains of bacteria present to enable them to predict which antibiotics are likely to be effective in treating the infections they may cause.
doi_str_mv 10.1177/147323000203000414
format article
fullrecord <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_72096114</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_147323000203000414</sage_id><sourcerecordid>72096114</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-f686288dea269c66885e8da7627c51f93ba167a7ae494a9ce35104e74de2a8ba3</originalsourceid><addsrcrecordid>eNp9kUtO3TAUhi1UBLfABhggjzpL8SOxkyEC2qJetYjHODqxT5BRYl9sR2rX0N2wkK6JRPdKDCp1Yku_vv-TfQ4hp5x95lzrc15qKSRjTLDlLHm5R1ZLWCzpB7Ja4oIpVh2Sjyk9z4hQlTggh1wIWTWSrcifK8xosguehp5e-OxGZ2LoHAz0DpNLGbxBCt7S618ZvUVb3G_mRpxG-ve1WIPJMEJCehuDnbYm5-n3AbvkcBiA3nqcxuAdIL3PEZxPtI9hpDe-nz1o6Q8MHjKmY7Lfw5DwZHcfkccv1w-X34r1z683lxfrwsha5qJXtRJ1bRGEaoxSdV1hbUEroU3F-0Z2wJUGDVg2JTQGZcVZibq0KKDuQB6RT1vvJoaXCVNuR5fM8laPYUqtFqxRnJczKLbgPJGUIvbtJroR4u-Ws3ZZQfvvCubS2c4-dSPa98pu5jNwvgUSPGH7HKbo59_-T_kGLdaRKQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72096114</pqid></control><display><type>article</type><title>Detection of Antimicrobial Resistance and Extended-Spectrum β-Lactamase Production in Klebsiella Pneumoniae Strains from Infected Neonates</title><source>Sage Journals GOLD Open Access 2024</source><creator>Aktas, E ; Yigit, N ; Yazgi, H ; Ayyildiz, A</creator><creatorcontrib>Aktas, E ; Yigit, N ; Yazgi, H ; Ayyildiz, A</creatorcontrib><description>The present study was designed to determine the antimicrobial resistance and extended-spectrum β-lactamase (ESBL) activities of Klebsiella pneumoniae strains isolated from the neonatal intensive care unit of Atatürk University Hospital, Erzurum, Turkey. Antibiotic susceptibility of 40 isolates was detected by the standard disk diffusion method according to the National Committee for Clinical Laboratory Standards Guidelines. The double-disk synergy method was used to determine ESBL activity, which is associated with resistance to β-lactam antibiotics. Twenty-four (60%) of 40 K. pneumoniae strains were found to produce ESBL. Of the antibiotics tested, meropenem was found to be the most effective (100%), and ampicillin the least effective (0%). With the increasing incidence of antimicrobial resistance, which poses a clinically significant risk to vulnerable patients, it is important that clinical microbiology laboratories have accurate and timely information concerning the strains of bacteria present to enable them to predict which antibiotics are likely to be effective in treating the infections they may cause.</description><identifier>ISSN: 0300-0605</identifier><identifier>EISSN: 1473-2300</identifier><identifier>DOI: 10.1177/147323000203000414</identifier><identifier>PMID: 12235930</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Ampicillin - pharmacology ; Ampicillin - therapeutic use ; Ampicillin Resistance ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; beta-Lactam Resistance ; beta-Lactamases - biosynthesis ; Cephalosporin Resistance ; Cephalosporins - pharmacology ; Cephalosporins - therapeutic use ; Humans ; Infant, Newborn ; Klebsiella Infections - drug therapy ; Klebsiella Infections - microbiology ; Klebsiella pneumoniae - drug effects ; Klebsiella pneumoniae - enzymology ; Microbial Sensitivity Tests ; Thienamycins - pharmacology ; Thienamycins - therapeutic use ; Turkey</subject><ispartof>Journal of international medical research, 2002-07, Vol.30 (4), p.445-448</ispartof><rights>2002 SAGE Publications</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-f686288dea269c66885e8da7627c51f93ba167a7ae494a9ce35104e74de2a8ba3</citedby><cites>FETCH-LOGICAL-c383t-f686288dea269c66885e8da7627c51f93ba167a7ae494a9ce35104e74de2a8ba3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/147323000203000414$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/147323000203000414$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21965,27852,27923,27924,44944,45332</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.1177/147323000203000414?utm_source=summon&amp;utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12235930$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aktas, E</creatorcontrib><creatorcontrib>Yigit, N</creatorcontrib><creatorcontrib>Yazgi, H</creatorcontrib><creatorcontrib>Ayyildiz, A</creatorcontrib><title>Detection of Antimicrobial Resistance and Extended-Spectrum β-Lactamase Production in Klebsiella Pneumoniae Strains from Infected Neonates</title><title>Journal of international medical research</title><addtitle>J Int Med Res</addtitle><description>The present study was designed to determine the antimicrobial resistance and extended-spectrum β-lactamase (ESBL) activities of Klebsiella pneumoniae strains isolated from the neonatal intensive care unit of Atatürk University Hospital, Erzurum, Turkey. Antibiotic susceptibility of 40 isolates was detected by the standard disk diffusion method according to the National Committee for Clinical Laboratory Standards Guidelines. The double-disk synergy method was used to determine ESBL activity, which is associated with resistance to β-lactam antibiotics. Twenty-four (60%) of 40 K. pneumoniae strains were found to produce ESBL. Of the antibiotics tested, meropenem was found to be the most effective (100%), and ampicillin the least effective (0%). With the increasing incidence of antimicrobial resistance, which poses a clinically significant risk to vulnerable patients, it is important that clinical microbiology laboratories have accurate and timely information concerning the strains of bacteria present to enable them to predict which antibiotics are likely to be effective in treating the infections they may cause.</description><subject>Ampicillin - pharmacology</subject><subject>Ampicillin - therapeutic use</subject><subject>Ampicillin Resistance</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>beta-Lactam Resistance</subject><subject>beta-Lactamases - biosynthesis</subject><subject>Cephalosporin Resistance</subject><subject>Cephalosporins - pharmacology</subject><subject>Cephalosporins - therapeutic use</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Klebsiella Infections - drug therapy</subject><subject>Klebsiella Infections - microbiology</subject><subject>Klebsiella pneumoniae - drug effects</subject><subject>Klebsiella pneumoniae - enzymology</subject><subject>Microbial Sensitivity Tests</subject><subject>Thienamycins - pharmacology</subject><subject>Thienamycins - therapeutic use</subject><subject>Turkey</subject><issn>0300-0605</issn><issn>1473-2300</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9kUtO3TAUhi1UBLfABhggjzpL8SOxkyEC2qJetYjHODqxT5BRYl9sR2rX0N2wkK6JRPdKDCp1Yku_vv-TfQ4hp5x95lzrc15qKSRjTLDlLHm5R1ZLWCzpB7Ja4oIpVh2Sjyk9z4hQlTggh1wIWTWSrcifK8xosguehp5e-OxGZ2LoHAz0DpNLGbxBCt7S618ZvUVb3G_mRpxG-ve1WIPJMEJCehuDnbYm5-n3AbvkcBiA3nqcxuAdIL3PEZxPtI9hpDe-nz1o6Q8MHjKmY7Lfw5DwZHcfkccv1w-X34r1z683lxfrwsha5qJXtRJ1bRGEaoxSdV1hbUEroU3F-0Z2wJUGDVg2JTQGZcVZibq0KKDuQB6RT1vvJoaXCVNuR5fM8laPYUqtFqxRnJczKLbgPJGUIvbtJroR4u-Ws3ZZQfvvCubS2c4-dSPa98pu5jNwvgUSPGH7HKbo59_-T_kGLdaRKQ</recordid><startdate>20020701</startdate><enddate>20020701</enddate><creator>Aktas, E</creator><creator>Yigit, N</creator><creator>Yazgi, H</creator><creator>Ayyildiz, A</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20020701</creationdate><title>Detection of Antimicrobial Resistance and Extended-Spectrum β-Lactamase Production in Klebsiella Pneumoniae Strains from Infected Neonates</title><author>Aktas, E ; Yigit, N ; Yazgi, H ; Ayyildiz, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-f686288dea269c66885e8da7627c51f93ba167a7ae494a9ce35104e74de2a8ba3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Ampicillin - pharmacology</topic><topic>Ampicillin - therapeutic use</topic><topic>Ampicillin Resistance</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>beta-Lactam Resistance</topic><topic>beta-Lactamases - biosynthesis</topic><topic>Cephalosporin Resistance</topic><topic>Cephalosporins - pharmacology</topic><topic>Cephalosporins - therapeutic use</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Klebsiella Infections - drug therapy</topic><topic>Klebsiella Infections - microbiology</topic><topic>Klebsiella pneumoniae - drug effects</topic><topic>Klebsiella pneumoniae - enzymology</topic><topic>Microbial Sensitivity Tests</topic><topic>Thienamycins - pharmacology</topic><topic>Thienamycins - therapeutic use</topic><topic>Turkey</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aktas, E</creatorcontrib><creatorcontrib>Yigit, N</creatorcontrib><creatorcontrib>Yazgi, H</creatorcontrib><creatorcontrib>Ayyildiz, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of international medical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Aktas, E</au><au>Yigit, N</au><au>Yazgi, H</au><au>Ayyildiz, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Detection of Antimicrobial Resistance and Extended-Spectrum β-Lactamase Production in Klebsiella Pneumoniae Strains from Infected Neonates</atitle><jtitle>Journal of international medical research</jtitle><addtitle>J Int Med Res</addtitle><date>2002-07-01</date><risdate>2002</risdate><volume>30</volume><issue>4</issue><spage>445</spage><epage>448</epage><pages>445-448</pages><issn>0300-0605</issn><eissn>1473-2300</eissn><abstract>The present study was designed to determine the antimicrobial resistance and extended-spectrum β-lactamase (ESBL) activities of Klebsiella pneumoniae strains isolated from the neonatal intensive care unit of Atatürk University Hospital, Erzurum, Turkey. Antibiotic susceptibility of 40 isolates was detected by the standard disk diffusion method according to the National Committee for Clinical Laboratory Standards Guidelines. The double-disk synergy method was used to determine ESBL activity, which is associated with resistance to β-lactam antibiotics. Twenty-four (60%) of 40 K. pneumoniae strains were found to produce ESBL. Of the antibiotics tested, meropenem was found to be the most effective (100%), and ampicillin the least effective (0%). With the increasing incidence of antimicrobial resistance, which poses a clinically significant risk to vulnerable patients, it is important that clinical microbiology laboratories have accurate and timely information concerning the strains of bacteria present to enable them to predict which antibiotics are likely to be effective in treating the infections they may cause.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>12235930</pmid><doi>10.1177/147323000203000414</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 0300-0605
ispartof Journal of international medical research, 2002-07, Vol.30 (4), p.445-448
issn 0300-0605
1473-2300
language eng
recordid cdi_proquest_miscellaneous_72096114
source Sage Journals GOLD Open Access 2024
subjects Ampicillin - pharmacology
Ampicillin - therapeutic use
Ampicillin Resistance
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
beta-Lactam Resistance
beta-Lactamases - biosynthesis
Cephalosporin Resistance
Cephalosporins - pharmacology
Cephalosporins - therapeutic use
Humans
Infant, Newborn
Klebsiella Infections - drug therapy
Klebsiella Infections - microbiology
Klebsiella pneumoniae - drug effects
Klebsiella pneumoniae - enzymology
Microbial Sensitivity Tests
Thienamycins - pharmacology
Thienamycins - therapeutic use
Turkey
title Detection of Antimicrobial Resistance and Extended-Spectrum β-Lactamase Production in Klebsiella Pneumoniae Strains from Infected Neonates
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A38%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Detection%20of%20Antimicrobial%20Resistance%20and%20Extended-Spectrum%20%CE%B2-Lactamase%20Production%20in%20Klebsiella%20Pneumoniae%20Strains%20from%20Infected%20Neonates&rft.jtitle=Journal%20of%20international%20medical%20research&rft.au=Aktas,%20E&rft.date=2002-07-01&rft.volume=30&rft.issue=4&rft.spage=445&rft.epage=448&rft.pages=445-448&rft.issn=0300-0605&rft.eissn=1473-2300&rft_id=info:doi/10.1177/147323000203000414&rft_dat=%3Cproquest_AFRWT%3E72096114%3C/proquest_AFRWT%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c383t-f686288dea269c66885e8da7627c51f93ba167a7ae494a9ce35104e74de2a8ba3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=72096114&rft_id=info:pmid/12235930&rft_sage_id=10.1177_147323000203000414&rfr_iscdi=true